Control-IQ Technology Provides Similar Glycemic Outcomes Across Two Different CGM Sensors.

IF 4.1 Q2 ENDOCRINOLOGY & METABOLISM

Journal of Diabetes Science and Technology Pub Date : 2025-03-31 DOI:10.1177/19322968251330308

Halis Kaan Akturk, Andy K Johnson, John B Welsh, Laurel H Messer

引用次数: 0

Abstract

The t:slim X2 insulin pump with Control-IQ technology (Tandem Diabetes Care) is interoperable with G6 and, more recently, G7 sensors (Dexcom). CGM-derived metrics from customers who transitioned from using Control-IQ technology with G6 and then G7 sensors were compared. Median times in various glucose concentration ranges for the final 30 days of G6 use and the initial 30 days of G7 use changed by <1% and remained within consensus target recommendations for TIR (70-180 mg/dL) >70% and TBR (<70 mg/dL) <4%. Differences in sensor use, time in closed loop, and median glucose levels were clinically insignificant. Control-IQ-based pump users experienced similar outcomes and achieved excellent glycemic control with G6 or G7 sensors.

查看原文本刊更多论文

Control-IQ技术在两种不同的CGM传感器上提供相似的血糖结果。

采用Control-IQ技术（Tandem Diabetes Care）的t:slim X2胰岛素泵可与G6以及最近的G7传感器（Dexcom）互操作。从使用Control-IQ技术过渡到使用G6和G7传感器的客户的cgm衍生指标进行了比较。在G6使用的最后30天和G7使用的最初30天，各葡萄糖浓度范围内的中位数时间变化了70%，TBR (

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of Diabetes Science and Technology Medicine-Internal Medicine

CiteScore

7.50

自引率

12.00%

发文量

148

期刊介绍： The Journal of Diabetes Science and Technology (JDST) is a bi-monthly, peer-reviewed scientific journal published by the Diabetes Technology Society. JDST covers scientific and clinical aspects of diabetes technology including glucose monitoring, insulin and metabolic peptide delivery, the artificial pancreas, digital health, precision medicine, social media, cybersecurity, software for modeling, physiologic monitoring, technology for managing obesity, and diagnostic tests of glycation. The journal also covers the development and use of mobile applications and wireless communication, as well as bioengineered tools such as MEMS, new biomaterials, and nanotechnology to develop new sensors. Articles in JDST cover both basic research and clinical applications of technologies being developed to help people with diabetes.